![John Harlow](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Harlow
Präsident bei
LARIMAR THERAPEUTICS, INC.
Vermögen: 159 750 $ am 30.09.2026
Profil
Mr. John B. Harlow is a President & Chief Operating Officer at Larimar Therapeutics, Inc. Mr. Harlow was previously employed as a Chief Commercial Officer by Esperion Therapeutics, Inc., a Chief Commercial Officer by Melinta Therapeutics, Inc., a Chief Commercial Officer & Executive VP by Baudax Bio, Inc., an Executive Vice President-Commercial by Recro Pharma, Inc., a Vice President & General Manager-Pain Business by Endo Pharmaceuticals, Inc., a Vice President-Sales & Marketing by Shionogi, Inc., and a Senior Director-Marketing by King Pharmaceuticals, Inc. He received his undergraduate degree from Lehigh University and an MBA from Stillman School of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 29.09.2026 | 50 000 ( 0,06 % ) | 159 750 $ | 30.09.2026 |
Aktive Positionen von John Harlow
| Unternehmen | Position | Beginn |
|---|---|---|
| LARIMAR THERAPEUTICS, INC. | Präsident | 29.09.2026 |
Ehemalige bekannte Positionen von John Harlow
| Unternehmen | Position | Ende |
|---|---|---|
| MELINTA THERAPEUTICS, INC. | Corporate Officer/Principal | 01.11.2025 |
| BAUDAX BIO, INC. | Corporate Officer/Principal | 01.03.2021 |
| SOCIETAL CDMO, INC. | Corporate Officer/Principal | 01.11.2019 |
Endo Pharmaceuticals, Inc.
 Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Corporate Officer/Principal | 01.01.2016 |
KP Pharmaceuticals LLC
 KP Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures, markets and sells generic pharmaceutical products | Vertrieb & Marketing | 01.06.2011 |
Ausbildung von John Harlow
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
54
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
KP Pharmaceuticals LLC
KP Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures, markets and sells generic pharmaceutical products | Health Technology |
Esperion Therapeutics, Inc.
 Esperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers biopharmaceutical products | Health Technology |
Endo Pharmaceuticals, Inc.
Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Lehigh University
 Lehigh University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Societal CDMO, Inc.
 Societal CDMO, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage pharmaceutical company | Health Technology |
Shionogi, Inc.
 Shionogi, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes antibiotics | Health Technology |
Stillman School of Business
 Stillman School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Baudax Bio, Inc.
 Baudax Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for acute care settings | Health Technology |
Melinta Therapeutics, Inc.
 Melinta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial-stage company and develops innovative therapies for acute and life-threatening illnesses | Health Technology |
Larimar Therapeutics, Inc.
 Larimar Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company focused on developing treatments for complex rare diseases | Health Technology |
